[
  {
    "title": "Breakingviews - Novo Nordisk obesity feast no longer a free lunch",
    "link": "https://news.google.com/read/CBMingFBVV95cUxNNlBTUk9qOGdmYTVqaXMwMmFFUlRFWGhNVE5Zdm5wa25uLVFnWVJvSWVyRk1GX1JINDBoTk9JTjRPc2hNWnJnaFZ1cDI5NDNhRG1mR3lzUUMyQkViczlWRWl1VWQ3NlZQTmFyRWFXVkpmZTFvSGtIUmVndUlNR2o3b2lZcmhPNEE2eHd0TWdFNjREUmtRbFhsQXRXMV9EQQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNVJNbEZFTlZWRmFEUm5kbWx4VFJDNkFSaVBBaWdCTWdZaFpJeU5LUWc=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-07-18T07:00:00.000Z",
    "time": "Jul 18",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk profit surges as it boosts supplies of Wegovy",
    "link": "https://news.google.com/read/CBMikAFBVV95cUxQY1FTOWZXUkRyTU5yMGFPRVVjbGxubnhua1FUWXk0cGpiN1hLZzBtZlQ4LVEzeEJBS0Rkdkh1VXVCREh4MExUOGQ4cENEM0cydjB5dGQ3ZmFidnFvZVRSeEJnMVF1S3g1Tm1tMWFrNmFuY0Q2S0VRQ3ZqaHF2X2ltQXJOT1pfX0pvNG9rRHJacUs?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNVJlbkJFWkdabVZUaElTVWMyVFJDM0FSaVRBaWdCTWdZQklJQ0dtUWs=-w400-h224-p-df-rw",
    "source": "The Washington Post",
    "datetime": "2024-01-31T08:00:00.000Z",
    "time": "Jan 31",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk: Back To Business School",
    "link": "https://news.google.com/read/CBMilwFBVV95cUxQcGs5bUJIbGFyWm5RMV9pV2xWTndra3lrZWN0MnBjSmN4TFZucmQxT2YzWnpsMXJXa09yQnpNa3JwSGFxRGg3Z1ZOcVBJa0R5T0RxdnZaaDh4TFBPVDZBal9ZQWp3c0E4TWZYdnhISWV4UVRVeHo5S3FQS1ZjbTI3VndZaTV3ZGtNYjNZYmxxMjU3VkN1TENF?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNDJjRTAwUTJoNFJFODJOekJrVFJDcUFSaXBBaWdCTWdZQkVJU2pTQU0=-w400-h224-p-df-rw",
    "source": "Forbes",
    "datetime": "2024-05-08T07:00:00.000Z",
    "time": "May 8",
    "articleType": "regular"
  },
  {
    "title": "Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs",
    "link": "https://news.google.com/read/CBMirAFBVV95cUxNemM3VmktUXpubXNPZFBaSmQwX2JEZFpaeTdfbU9BOUxGMDRRZGJHMHJLa2VVQXJ5QnlqWEcySzVFZFlTQ25tSm1qaGllLUZHNHBGSUU3YjBxdXFFZHRQZl9RcUc5TndXbjNEQmRlWnJ3cWJoVXZkMEk3c2tFa0JZSkFJNXFheGZ2dHhnU3lhNFlWQU9HQ280eHZEOXFlVWVPNF9GZ1J5TmdOaktS?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNDBhblo2UmxWRWFFeHpXaTFEVFJDb0FSaXNBaWdCTWdZbFk1ck5KUWs=-w400-h224-p-df-rw",
    "source": "Pharmaceutical Technology",
    "datetime": "2023-09-01T07:00:00.000Z",
    "time": "Sep 1, 2023",
    "articleType": "regular"
  },
  {
    "title": "It Introduced Ozempic to the World. Now It Must Remake Itself.",
    "link": "https://news.google.com/read/CBMiggFBVV95cUxPMEdKalNRQ2t1ZHQ0N3g5anlSV1ZkYXZFLS1nNWpCYXZVcV9BZkxIQl8yNG84YVlPQjV0N3lKZWNCTFBvaWVGbTRWb2t0cE80NzJPMnlwOEJqSEpYX2R0Uzh2bHJncG8tVURncHhXaTBXQVNtallBTXN4dUpseUdjV3FR?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNDJaMVpNY214VVlYcFhWVFZHVFJDM0FSaVRBaWdCTWdZQk00UUtJZ2c=-w400-h224-p-df-rw",
    "source": "The New York Times",
    "datetime": "2024-04-20T07:00:00.000Z",
    "time": "Apr 20",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic",
    "link": "https://news.google.com/read/CBMiiwFBVV95cUxOdGtIZkQtT3B3RllnY1lPdXhaLWNBdFlVNGxZcm14Z2xpQ1lKNEktWnlSQ21jUWN4U1FUVEhqSVVBODVaNnVUeDZqVzY5RGtFMmdraXlHU0ZEa0xKZ0hmS2dtLXFvMzd3aXNGREt4S3V4a3RBWFhRNVdtdENvc2lqNnhMZktPRVdSaVpv0gGQAUFVX3lxTFB2SW5pV2VfTnpxZkhrNEZlTUNrVjVRYWU2dW52dldlbUhETEttNDBWZE91VEVWbllfeW9aNFZ6cFpyWXJFdmNCNl84Y3pJOFVhS1hfaDlFOUdxVlk1c1V3TzNNOVpYaFpmT3BsX2Y2NjVPS3RneW1sOUV2ZlJwMk5uNE90amxjbFVxVk9TRUZDZw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNU9WMHQzY0doVmNpMXdhSEprVFJDb0FSaXNBaWdCTWdNQmdCQQ=-w400-h224-p-df-rw",
    "source": "CNBC",
    "datetime": "2024-06-24T07:00:00.000Z",
    "time": "Jun 24",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk Foundation, Wellcome, and the Gates Foundation Join Forces to Accelerate Global Health Equity and Impact",
    "link": "https://news.google.com/read/CBMipAFBVV95cUxNdWJmZEV0ZlhFUTE3WmdqWWdvWk9oLVRtUUE2ME0xdzczc2xjdGhoVHlSd0NCNUtyRlR2bjZ0Rks3QkVnSEVZUzdPNndvS3QydFh0dTBJYUcyZWJEbmxnei1BUFZqVkkxNDFMdXVuYzBoM0c1MWdmS0cteUZWWm9PYUR2MTNoMmZCRDd2cXlxQk95LWJLYndEeVBFNUY4X3FBVi1aVA?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNUphWFIwTUVkcmJVMUpVVmhYVFJDb0FSaXNBaWdCTWdZTm9wSUl1UVk=-w400-h224-p-df-rw",
    "source": "Bill & Melinda Gates Foundation",
    "datetime": "2024-05-06T07:00:00.000Z",
    "time": "May 6",
    "articleType": "regular"
  },
  {
    "title": "Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management",
    "link": "https://news.google.com/read/CBMivwJBVV95cUxNblRMenNCcGVUdUdLemVDNlBobFBYQzJFSS1JLTd0NFh3MGpmYUFBaHNnNFdTWHROdUtYU1lNeGJwc1pGWEdQV0pXQVBwQnJRWU4zOTh4YWFiQ1VmbFY3ZzFhNktVck5XU1Z3bW5MMzZZS1d6SnBZRVFNS0llUDBYc1FQaXdMQVFUUmp1bEoweXdjTXY5emhkNUhmdElJZDQ3Z2RtLVd6UjR4WHlyaVdoX1YwQjQtN0pURzg4MlNIWjFhbm5UakM1VVlqNFZic1F5ckxlM0FhMFE0NzNSTHNXMm5qVlJJc1htc3N5dXlaSFBsSUdLRmttOVFEZGpPNWl1TlNoWHBLWWhESDB0V0U4bEdFT1Y3M2U4Ujlpbnc1Z1RWeUQwenZYVEw0eDMzUlQteDNQUnZheVljXzB1Rzl3?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iKkNnNWxWMWN0YUhkU1JEQmxSVlJSVFJCVUdLc0NLQUV5QmdrUWlrOFZDZw=-w400-h224-p-df-rw",
    "source": "PR Newswire",
    "datetime": "2024-05-09T07:00:00.000Z",
    "time": "May 9",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk owner to invest $200 million in quantum computing startups",
    "link": "https://news.google.com/read/CBMisAFBVV95cUxNWHBLWExtbkZqVlhIODVsTVBhQzNnbDZRZkhMTXhxS0lHZEpERzFtZEVZTG4zSWFHUWhTWW0tNk9CVFh0bF9wNUFRMl82bl9YLTNPaXROSWszclppVWY3cS1ZY29KNUpDU3FiTHhfUWJfNjgzVUtLcVJmNnJ4NnZnWjlQRE9EeHE3SzV1ZGlSR1hpN2ZHaHBvaXpwQmdtMHRmQ2JPTUtNWENCTnhwQjJGTg?hl=en-US&gl=US&ceid=US%3Aen",
    "source": "Reuters",
    "datetime": "2024-05-01T07:00:00.000Z",
    "time": "May 1",
    "articleType": "regular"
  },
  {
    "title": "How Ozempic and Weight Loss Drugs Are Reshaping Denmarkâ€™s Economy",
    "link": "https://news.google.com/read/CBMie0FVX3lxTFA5NzExellBQ0JYakJBWWtLek53LVhPeFRySXMxdmtMdzZBbUtsSDJubV8xaFZENTlsdXY5SHJ1dWdMaC1CUFcwTloxN3NPWGxhTzhOQmtzZVZtQ2JBdWgxR1YwTHlETG9uRkVWR1c1X0gwV0RYWWE0Zlg0cw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNUZRVGRUYmxOS1EzbDZPSEUzVFJDM0FSaVRBaWdCTWdZWndJcUxTUVE=-w400-h224-p-df-rw",
    "source": "The New York Times",
    "datetime": "2023-08-29T07:00:00.000Z",
    "time": "Aug 29, 2023",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk briefly overtakes LVMH as Europe's most valuable company",
    "link": "https://news.google.com/read/CBMixAFBVV95cUxQaV8zOXBfVU13UzhKZkZIRHZSNnl4TlBlM0Q3b0R1QmU3TjA2b0lNY0N5Rk9oRElqZzBXa3NxUFNyb0FRamtOTTdUVmZCNnZxMXFFd0JaWTF5UnQ5STVSLWtOVk14RDV5R3dkeS1ESVNFbUU4NGJxVUtzMzFmSjBhWXpiR2RVVmQtT2lOTEVXTWFKVmQ4N1lSQjhXMTFGUEx0bkV4TE1Cbm4wOVRUY0dtV3hKZWZpMm00LTRVX0dKT2VBdy1u?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNVRUbDlyVW5kcWVrMVhNbFZDVFJEREFSaURBaWdCTWdNSkVRNA=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2023-09-01T07:00:00.000Z",
    "time": "Sep 1, 2023",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk, Lilly see insatiable demand for weight-loss drugs",
    "link": "https://news.google.com/read/CBMiygFBVV95cUxOaDZzRVh4Rnh0VXprUzgwSVJfcGtvQnU2MmFzbHZTR180YmpTVTc3cGhJOHVOTVVHVC0yaEsybHJvOGhvYXJwaGNHdkx0cEkzMU1LZXFZcEZRVnBIdllLdGFpYkdIMk4ySExWbDF0Y0ZzcXd3akFnYjFNRkJQc3kteGJKZ1pObU5HY3NmTHlQczhhcDBnVkVVQzcycmZlOVc2M1poZGcwYkNtLUtzdHdkSVpIQmRLVXdpMWIzUFhXdzFZNU1MRnZCR1N3?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNU9VbkkwZUVGTU5XUmlMVGR0VFJDLUFSaUpBaWdCTWdhWlVvaExPUVU=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2023-11-02T07:00:00.000Z",
    "time": "Nov 2, 2023",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk, Lilly must cut US prices of weight-loss drugs, Biden says",
    "link": "https://news.google.com/read/CBMi1AFBVV95cUxPaDNjdEppWmxrWGw2RkJkVjNNNzJacURNLW8zdzVhMEdjNllRaVY2MFM1ZjhOZDR6WFZQbmJmMkFOSmNwZGRHM0Zxa2tkaTh2TTJXWmktQ29nX2UxY3E0Ump4QTM4cnd4Y3Z1ZDdPTld2RzZ0Q0lqNWJiVzhfeXpqRFlVMVR1RHU3eEx4d185eXVQVUhjT01TTjVucHZtTUwxaVRUNlRDZ1ozZDF4SE9DdHplR1BSZlEtRVdzTXRMUlprUjJkNFZGa0hBWE1qTUZER0h1RQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXljMWhMVFRNdGFXYzRMVnB0VFJDaUFSaTNBaWdCTWdZdFZZYVBvUWc=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-07-02T07:00:00.000Z",
    "time": "Jul 2",
    "articleType": "regular"
  },
  {
    "title": "US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic prices",
    "link": "https://news.google.com/read/CBMi5AFBVV95cUxPdV9CcDl2ZklkWjNsRnFyUVZZWXJNV1YwUlJ1eENCV2dmdTRDX3Q4SHdYd3NYYkhTWXoydUNWQXotSE1ZQi1xN1lkOS1OUllaNjN2bDZvaTlrdU04SXc3MVEwczFqT2I2VUtOOXRXaG9ZeTBoWFZKSThVWGlGRHJrWUs4MG1xdEFVUFJaQkxJS2FKQ3JCaGpQUGpZUS1UYi03LWV2bVZ3LTV0RnRjMkRzWU1FSDVZLWRWbmJQTGRtaTk4TnNCMDlDdzU5bUMyTGszMm5lY2ZUZ1owaEVuamUxdDVTUzc?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWliRk00ZGxwb05YaGlTMDlKVFJDM0FSaVRBaWdCTWdhWlJaYk5LUWc=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-07-11T07:00:00.000Z",
    "time": "Jul 11",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk trims price for blockbuster obesity drug as competition heats up",
    "link": "https://news.google.com/read/CBMixwFBVV95cUxNWFplOE93VGQwd2tHU0w5Y1o0a0xJWkctNTZRcy03ODV5SkJYOXlEdnVmLWE4cF9uZnlnbXVoN010ZElHenlyN2MyRTNnZTFnaHJxNUE5TThZOFNja3lOdUpRSzgxdnQ4TkdWa1BEd0ZqaFNaWUpDZEQ4YVNpTEhyVHFzbHd3OVNWa0ZwNkg2clo3a1Mtck1HelJmRFU1eXlVVmU3VWZ4N1hwVlcxdjBzZkxXakNBYjNadmx1eG5rQWZ2VldLQzYw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXFRVlpVY21KaGRrVnRXalpaVFJDaUFSaTNBaWdCTWdZUmNJcHBzUVU=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-05-03T07:00:00.000Z",
    "time": "May 3",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk to discontinue Levemir insulin in U.S. market",
    "link": "https://news.google.com/read/CBMivwFBVV95cUxOcHF5dGRMOFZfbW9kWHJhbVhKcm9vcFpVcEJfdngyNk5BTzJXNDVXaUV3SGJPLUwyVDd2dVBHelRmN0xWcnNEbVFIUDlUSjFlLUQ1alo2MkpLYzI2c2ItRGFSYVVRSWZidnZRNWxiU29PUENZTEVlVE4zNzBpUEdFdkxETURtdV9vOVBZWmZwOGtaMWhUQXhvZkJNcHJ2UEt5blNWZ0l2NmNyZnhtVEExd2MwNDllWjR3ZmJVd0NUdw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWxWRWczTWxwMVJuVmFjV2c1VFJDLUFSaUpBaWdCTWdhWlFvaHJPUVU=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2023-11-08T08:00:00.000Z",
    "time": "Nov 8, 2023",
    "articleType": "regular"
  },
  {
    "title": "Lilly, Novo Nordisk battle for weight-loss market lands at the pharmacy shelf",
    "link": "https://news.google.com/read/CBMi0wFBVV95cUxQcWRYODJJdm96aWwweW84UkVja0FtSkxlb2o5S2hLSGlvUW9hZlI1enpQa2c4VndKWVBUR1hDNmFYb1JUbThrVldvYnFmbFAzOEhUWDdIMHJEOUV2RDlYMExHWElPMkgybmFEcU9ocllvMElCcV9uRGZncERRWXM0ZHVNaWFqV1JrUXliTVE0UWsyZG9sWlNIaDhGdy1aVUpnWjFjQmhMU0VqaExHUUp4MjdUSTJlRnhrUnhWVW8tbGdxZlc4Z0dPNW1SWTNnZkh4dkNF?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNVdZVEZoT1RkdVUxUjJWRFZtVFJDM0FSaVRBaWdCTWdZQklKTFNvQWc=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-08-06T04:21:00.000Z",
    "time": "5 days ago",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk shares down after analysis finds Lilly drug leads to better weight loss",
    "link": "https://news.google.com/read/CBMi4gFBVV95cUxPdjdFNUFibW41QXZEMUdDTVpYLWdTS281YUZlNEdaSHBTR3BRX0c2NThORFQ0R3hWYW9nSW40aXRhNVowc0JvZENEZEhpaVNUTjBOUUtlbHBiMXAxcGc1eXVRYUgzQjlkN2ozVGpnY0xfa1BrNWJQSFp3cG4za2hDSFlZOGh1Rnd2aWNmNHloTE1pT0Nfc2txR05ZaGNVOVNtMW16a2ZhMlF4WU16VHhLYmdtOW9CMjFKemlEal9XTlA0ZTBVOWdkWi00ck9pVmItNjBMS21XSU9PZFEzYmE0R2Vn?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNVlNRE5OTmpKbVdFRlpWREE1VFJDM0FSaVRBaWdCTWdhTlU1REdvZ2s=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-07-09T07:00:00.000Z",
    "time": "Jul 9",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk expects China to approve weight loss drug Wegovy this year",
    "link": "https://news.google.com/read/CBMiwAFBVV95cUxNd3Rnc3ppR21mZE5HbFk2Ulk0bWxTUzdZbVdhQW9YOXN5M0NmUm9YLTlQbV9pb1ctYjEzYTBVbi1tR29vdndwSmlnZm1uMWY4d0JDdUxXUnRSOGs5U2NnTkgtRUFjZVBES2pEZ1Q4WkpCTmNrUkh3emxfeXB3cEI4bkUxMW1ELXZ6LVl3X1A5VS1rWmVTeEliR2hBSS1RWW9ENEhneF9acFBPZHNsTXRMb2EtblR5MTVWN203bEp0el8?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNXhTVEYzWTFwcVVrMXdRbnAyVFJEQUFSaUhBaWdCTWdNTkFnbw=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-03-07T08:00:00.000Z",
    "time": "Mar 7",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk owner readies for big Wegovy windfall",
    "link": "https://news.google.com/read/CBMiqAFBVV95cUxPWDBtQzZQZ1pheVdOdHl6VnFzbEViXzFtamt0bXVRTU16ZUF5cElPYTB4aVE4RFNXc0s5Nm56WG1xek93WWQyaGJxTWc2TEdyMWVDajJwQTBYWEpobDZQaFk5ZWdXUlk0N0lmUlFxU2s2cjdqRVVsREpEQjVtTDdtQXlKUzAwZFNYYmJmUnZmb21jeUthVUtzb3pZVXdZRk9BaDZTSDlOekk?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNTFURGQ2V0RaelEzcE5UWFJKVFJDM0FSaVRBaWdCTWdhcEpZN05sUW8=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2023-10-04T07:00:00.000Z",
    "time": "Oct 4, 2023",
    "articleType": "regular"
  },
  {
    "title": "Ozempic and Wegovy maker â€˜just scratching the surfaceâ€™ in meeting demand for weight loss drugs, CEO says",
    "link": "https://news.google.com/read/CBMijwFBVV95cUxQUVFOM0R5Tl9YMXd3RmtleVhhX1VaS2R2UlR5ajRBbjlnTlo3cWU1V05QUHF2bTZ4NDctY1NJNVFJdXRncFRhOGt1VXV2SkxUODFYU0RJa0NSVkE5cVRCd2RxSEZ2RzhmdnRCNG5ESUNjUzlBWWtIamVTWUdyZE9GWHRWNTFWZGVNenVteFRZc9IBhgFBVV95cUxOX0ZkRVNrQXcwMHNBUmpTYjZrc1I5OWVoMHFqS2ZEOGtDbGh6aTgtRTZ5Q28wU0RLcjlLcVRhRFYyeVhWa3FMcXNhaXR2V09YYTVpMmM2X1drdkQ2LUlRV0xFTlR4V3FhMHV2d1FBci15bkdMb2F0LXdMamU3WTVQa1FsT0hEdw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNTROMDFrU1VoTVFsbFhWRWxPVFJDUUFSaUFBaWdCTWdhaFE1Q09wUVk=-w400-h224-p-df-rw",
    "source": "CNN",
    "datetime": "2023-09-05T07:00:00.000Z",
    "time": "Sep 5, 2023",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk's parent to buy Catalent for $16.5 bln to boost Wegovy supply",
    "link": "https://news.google.com/read/CBMisAFBVV95cUxObmZFQWdFbFRSVE56Y2Ntal85bXFYLW5Bd3gwS1prQVAyOElKRm9jNDl2RlYwNkdFUXJWMzlOeC1YWFFZVTc2TmJ4Sk1Ia04xZkZ0MVRqMkhManVBT0VOQ0lneVltY3A1ZmJBQW1TMExtekxGN2dKQng1ajRYUURtcWRvMV9XeWJVdVd0dGEydnRWVGNhZmZLUTBweElyaUI3bkJMUFB1bVdnaHp6OUluRg?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNDJhSFpuVFRSaFVXaFJjMGx6VFJDM0FSaVRBaWdCTWdNQmNBbw=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-02-05T08:00:00.000Z",
    "time": "Feb 5",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk announces $6B investment in Ozempic, Wegovy amid shortages",
    "link": "https://news.google.com/read/CBMisAFBVV95cUxONXA3S3JvUXRLQTE2Zl82OXFubGVfaEZnTlljZTJIX2I4Uy0tSURSb29vQzZwYldZMk9IYk53UTVlM1RpS1BSakhKbjQwMmtJU0JmUmVUXzU5cVFVQWhBVFRoQkhYQWlVOTRhc2dlSUFqd2RBQW1MaEdBcU1leVBCRjM4cGNtSEtienNiWWN0LXlaZU1LaUlEUko3QU5WQ090aEFTQklpeXU1elJWWVY3NNIBtgFBVV95cUxOVnRidlJ6WS1TTGh2bHBxQ0toY19WY054X0owUk1jNzlmMkFIYXRTUlRybmVMbW1fejI1WG93NURBbmlxWkc3NG1yUG8tTUh5S09YSWxKTmNLNWQwcXRqNC1ldXhoZjdBWVExV0RTaTlQSnk2Y1dpWGZ4S1VpRk9Pa2FqMWlfa2RuUzllNW0yTVhCQUJKTU02NVJrM2R2TWVUeC1UYjRkNXVXS1YwS2lfdVZHRGVXdw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNDNlRmRuTFhGdExUQTNSVEEwVFJDb0FSaXNBaWdCTWdZeE1JeFNLUWc=-w400-h224-p-df-rw",
    "source": "ABC News",
    "datetime": "2024-05-02T07:00:00.000Z",
    "time": "May 2",
    "articleType": "regular"
  },
  {
    "title": "US FDA declines to approve Novo Nordisk's weekly insulin",
    "link": "https://news.google.com/read/CBMiwgFBVV95cUxNRVUzQnM3b29HU2FrN0g5Unp1SnlMYkVVOTVfM18ya3N4eF9USDJYR1BDTnB2TWlrU1BMUVJQcnV4Tk5OeHN2RzU0SGJsS0lhbzFFY2NTdXpmRUdfVHVUVTQ0WlJNVC13d2dhVkphYkJaQXdPek1fOTJZVTA0b2huYWF3UVRzOE5xS0RndmM5UWpTUmNrMW8xUUI3bmM3NWJDZ2E3bWQyMHd1XzlueEl5dW43S0dyODEzcy1ZUFVlUTE3dw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iL0NnNUVaRk5ZUVZFM09UbHRVbXBVVFJEQkFSaUZBaWdCTWdtSmNvaUlNU1pVRkFF=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-07-10T07:00:00.000Z",
    "time": "Jul 10",
    "articleType": "regular"
  },
  {
    "title": "US Senate panel to weigh Novo Nordisk subpoena over Ozempic, Wegovy prices",
    "link": "https://news.google.com/read/CBMi2gFBVV95cUxQS0R4czUxQkktTVBkSm1yZXUyOGxDRGtnU0ZELTh5QVNxWUNlNlM3TWRxSllwZmhMbm5NWlFaN25VWTl4VHBZd1hVSlZIREFPWXp3dmpGZk05enR4ZmJNa3dkNGhqT2l0QnphWVk5TXVoTkh0cXJKeGd5QnJ4QVg4c3BrSmxyQWF0NXFnSGVUYmpScDRnbmk0dVUwamx5LWdoN1NXcnEzZ0VDdHNVRkpOWFZoRWJVT2VMNmEwdlUzOWdqM3llajBrUDNFckk2eUZLOHRWYzVfMTFUQQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNTBibGhZU0dSTWRVeHNWMk13VFJDM0FSaVRBaWdCTWdZaE1wUU5JUWM=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-06-11T07:00:00.000Z",
    "time": "Jun 11",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk, Indonesia's Bio Farma sign deal to package insulin",
    "link": "https://news.google.com/read/CBMirgFBVV95cUxNZTFtY0l4LUk0Zm5kZGdjS05WZ3lZZkZMTUtRbnZVWXl4X3ZIUk5QcWtqdnJSRlFBQ1NaRmFEamFnenF0YUV0Yzl6Y1Fqa1pRM2dqam90ZWItSDN0YWJxTW82ampxMkFQT1NDRldjam1RWHNBSVluRjZIWVFHVlYwbVZKTnBOc2FfSXBQUUt3d2dvekpRQ2hPNWZ0MURqdzlWTFJEblBDYll6T2Uwd2c?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXNkblo2ZVRRM1pHaElSblZ1VFJDMkFSaVZBaWdCTWdhMWtZb1NzUVE=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-07-10T07:00:00.000Z",
    "time": "Jul 10",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk posts rare miss on sales of obesity drug Wegovy",
    "link": "https://news.google.com/read/CBMixwFBVV95cUxNRGMzaFNCWm4tTkZYSmxHemdkMkVDbHltdEhtcGNieFFaZWpBQnk0bWpfSmFOUzV1b21MRzVTekpzNHlZbGFEMlhyQld0U0JiOHJJN1FISjlQd1p3SzFQZUZnYzVmdTVWbmxteG42VWpLdVhVZjdRU1FhSmQ3bVBOTFFLVnZ1Uk9pdGlBd0NfRS1VX3ZIS3dCUGJCN25kWmxTMlZMN2U2RTk2STl4dlgwb2hMYVdTbEU0NU5Ram5EVEp5LXJVdGdr?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNW1UMlZQZW1weGVGRk1lVXBLVFJDM0FSaVRBaWdCTWdZaE1wUU9KUWM=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-08-07T15:35:00.000Z",
    "time": "4 days ago",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk CEO 'confident' Catalent will resolve Wegovy output problems",
    "link": "https://news.google.com/read/CBMi4gFBVV95cUxQWFNrTl9yTzBXc1RaWFZEUWxLbnl6RkFMaUNxcTBnS1ZaVElnRHdDVXJ3OGdxeVAwOFNrbHpqUlh2RkYyQzMxTTV2dkhvemhURXV2TTZ1Y1JuNy1XMWQ0ZnB0OE1Rc2FZTDA1emlBRFhaUG85UDBSbFZtTnVFQXdJLTBNYW9JTkNpeXQzbVdfbGZXUHhWRXpKUjF5bmZTeGJvMEhfeFVIVDdCeWpQVG1vX0xyMEtpcUNXeWtRSkVjXzV2TlNCX0syd0s0VFZ4ZG9qbU5iQ0R1b1piYXJDdzBuQXFR?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXhhRkphY0VaV2FqWnBWazQ1VFJDMUFSaVhBaWdCTWdhSmdKTEpPQWM=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2023-08-25T07:00:00.000Z",
    "time": "Aug 25, 2023",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk to increase supply of weight-loss drug Wegovy",
    "link": "https://news.google.com/read/CBMijgFBVV95cUxNeXZCXzZTckotLVY4VEZTekxqU1c2QTFOY3ZGRmpGcXFPcjJNNzB1bUhWYU9ZRXoxMHE1QU1jR1FBR0xOeC1IWGxBRlZpLU1uU1dLUUZSb1VvVXc4Rzgza3FvQ1R3cFlfSFJPS3otVE1JN1BSMEVUdmY0RlUzYmZhMEprM2lpaWczMGUzRmNn0gGEAUFVX3lxTE83NmQ2Sm9DVFNwM29URHRfZHhLQmZ3ZVpXZVVzdW5UcnJLdjE4YkJFRGFQbl9FSS1zYnFoRDlkdXcwLWlWUHpQS0Vqa1EtaFUwUUtYbnNSeVc3eS15d1VwX09rZ1QtQTlCak04R1U1WEtyVll6cXRWS0FFT0ljVVBoRmt1RQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNU9XR3hPWkRJMGVHTlNaRzFMVFJDb0FSaXJBaWdCTWdZTmNKYnZyQWc=-w400-h224-p-df-rw",
    "source": "CNN",
    "datetime": "2024-02-01T08:00:00.000Z",
    "time": "Feb 1",
    "articleType": "regular"
  },
  {
    "title": "'Vaccine-likeâ€™ obesity drug is on the drawing board at Novo Nordisk",
    "link": "https://news.google.com/read/CBMifEFVX3lxTE50clZrY2dGVnctUlBVTDJoQnFKb28tZXRtV3NFWWIxdlY3X0JXaVRtM0dUNG9uazdqMmo0OWNMbWVRYVJHYkNZS0RacXZCcUpFUXR1dTAwNE5oTW01N0xra2lyb3FWQ3hnN2tZcDlHaWZueEE3cXZXWHJGVXk?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNW9WRGN4ZVVSeFpsWm9VV1JtVFJEaEFSamhBU2dCTWdZTng0NW1QZ1U=-w400-h224-p-df-rw",
    "source": "STAT",
    "datetime": "2024-02-29T08:00:00.000Z",
    "time": "Feb 29",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk owner buys majority stake in Austrian life science tools company",
    "link": "https://news.google.com/read/CBMiwgFBVV95cUxPa0VqY1hFLWRybVpDbm0wLWtDTEVQc1RjTzBCMENqOUFFY0I3dWp1dnUyU3ExTjVsVTFvT0dpVjVyZ1ZnM3d1MEFRUmo0QkNCY1oxaXNUZVlvX05icXJtSDhEZWFVckgzb3dTU01kOElBU1dxUk5CVHVHcWxvc2Utam9PaUtMNTNiNERuWTRtRW8zd0s1aDZoanNqRG9wN3ltQ2JSX2lZaVRRRWMtVXlTN0xxTDlTOFBZa3Bud1JRbzg0Zw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWhNelp1YjNKNWQyTnZWVVEyVFJDM0FSaVRBaWdCTWdZbEpvUU1HZ28=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-05-15T07:00:00.000Z",
    "time": "May 15",
    "articleType": "regular"
  },
  {
    "title": "Wegovy makes UK weight-loss debut even as Novo struggles with supplies",
    "link": "https://news.google.com/read/CBMivAFBVV95cUxNc0JPWkJ3QmRzdGp6ckRwMmxzR3RFNDJyWllYUWxmMmhZaU00ZGJfSTRtV1BOZllTb3RIRXhKbnQtVkNiVmJpLW1IZFZfMFV0WHdaVVlYU0dzdVhJMTM3SGV2Z3ZqVWE1WG5ycW9NX1o0R1hKNGJJUHVzb2RZbXdFdjltSGRmck8zRTZXdUlDb21aY1R6WjA4Vm5neEMzdndURDlJbGpnaFlFdmRiNVBabHNQRjdUWVJMcEtHaw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWliazFhZW5CeGRHZEVaSE5LVFJEQ0FSaURBaWdCTWdZUkJJUW1rZ3M=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2023-09-04T07:00:00.000Z",
    "time": "Sep 4, 2023",
    "articleType": "regular"
  },
  {
    "title": "How Novo Nordisk makes its weight-loss drug Wegovy",
    "link": "https://news.google.com/read/CBMivwFBVV95cUxQVlljN1ZuTTdXeUN6ZkdLNE1Nc2Nsei1YMUJVaUhIUklqT2hJbjZySklZdWJVSjkzVEJRQ3Q2d0hfRW1kUTdsSVFoYk1vOTN6aVh6ZHhOWUtQNmwyRXZNOGhhUDhSZkdBcUh3SEMzdjd6RThUMFU3dEJwUHlTYU96TUtJYVpkQ1A3S1ZpWnRCNmZnRld1aVNYRkpLNlZVNUtfWEpvSnhiYUdFTXFFbFpLd3EzZmswMm9kb19xNjAwaw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNDRZMDFwTUU5UVUzWXhSMDlyVFJDMEFSaVpBaWdCTWdZSllKQ0dwZ2s=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2023-11-01T07:00:00.000Z",
    "time": "Nov 1, 2023",
    "articleType": "regular"
  },
  {
    "title": "Fire at Novo Nordisk office building under control",
    "link": "https://news.google.com/read/CBMijwFBVV95cUxNWm1JWkIyb0hxcGlsbTlpdjlZRHJwZXE4S2w4QU5takdiQUlrYmFnT2R2ckNMeFc2R0llYlV0WEJUbFFBVng0ZmJZaXIwU3FTclZkS3VPNHFsT19Dc0hUcnNVeXlnX1RxU0NPc0lyemRfRjN0aXNjZ0otOFU5UzI5UkxHdEtzQnYwN05MT2RmZw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWFSR05XVnpVMlZuSlhOVVJzVFJDM0FSaVRBaWdCTWdZQlVJU2tyUVk=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-05-22T07:00:00.000Z",
    "time": "May 22",
    "articleType": "regular"
  },
  {
    "title": "Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug Frenzy",
    "link": "https://news.google.com/read/CBMiygFBVV95cUxPN1JldHI2X3R3OTYyR1ZsampWMFYta2xLUjZ5NjQ5Ujg1RFUxQjJOVFg2R1F3a3hzZmFJYWRPMzZycE5DdTVHal8wZXZqa2wzSE5wb0RCYmZxWkFsYVRlSVFSRk4yQVRUSnpZSTRIcWtKbGNGTW5uWFUyMWxlVU83aWJVMDg2cXhyUW5YYWVmcFhPekYyWkFUWFRDTkhCOXpmNDRIdk1zX3NvLVNxUEFoLW5UcXRramowSUVacHQxODYtaUJjakdEeVJ3?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlSMDQwTW1obE1tbENkeTFGVFJDb0FSaXJBaWdCTWdhVklwRE1LUWc=-w400-h224-p-df-rw",
    "source": "Forbes",
    "datetime": "2024-05-02T07:00:00.000Z",
    "time": "May 2",
    "articleType": "regular"
  },
  {
    "title": "Wegovy maker Novo Nordisk sues nine spas, clinics and pharmacies over copycat drugs",
    "link": "https://news.google.com/read/CBMi5AFBVV95cUxPSi0xa3prb1JCUVZmb0hXTmEzMFplclJFTExZdmxvVGVWNWNwbFlVUGJvellEYTNXMDAzUFVaREZRWFkxMUNuZ3RPVklaNWlGU0pDa1R6Sm5VUjFnSVpHT3BibWVNT0ozTUdkS3BMUlBfVl9rZy1pR3N6dHpyV3U0RE92Z0xTNXFfcGFjX0Z5cEdyTXM0TVpraFJTLWhJYTBrMmoxRnY4NFVrVl9BZkxIR29KMUxEcndvVXVqR01HdDV2NG04NkI3MlFTZEoxaDFsQURVaEthbldsMm45REw2dEhiTjQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWZhMGhHVERFeWJWOXlRMXBsVFJDM0FSaVRBaWdCTWdhTm9aRHVOQWM=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-05-30T07:00:00.000Z",
    "time": "May 30",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk reprimanded in UK for failure to disclose payments to healthcare sector",
    "link": "https://news.google.com/read/CBMitwFBVV95cUxNcGpocEhnbHRxdkNNcmlKV0FUdVZFOEFDbXE5dHNLM2t2c1hKUUNZUEkxSEhEdmVuNzRZa1NaRW5UM0FIM2Z0TER2QjdnTkxJeEN5Wi02VGd3Tl95cDMxTEtpeHJ5OE85UV96TkptSlQyODc3ZVNjeERsbm5vLTJBZGFidE1oZFR0em5KX1Jwb3ZQMW0yN05kZnZBbXNoZUd4alBaMHAzVE4wUlQxSW8wYkZ6bHFPdWM?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXNkblo2ZVRRM1pHaElSblZ1VFJDMkFSaVZBaWdCTWdhMWtZb1NzUVE=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-07-05T07:00:00.000Z",
    "time": "Jul 5",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk settles with Florida spa, clinic over knockoff Ozempic",
    "link": "https://news.google.com/read/CBMiuwFBVV95cUxNSFlvVXlNSDNtVElCMTc2TzhsbWk5MURuWk5XZ3E5aDlnb3FGRFEtVTRnNGFiS0NOSVdyRTlrcXNlYXkzbXJYWWFaVllscFJWT09ZeGNrYjFfVU9raVUxV241R2dOYmZqRTZ1TTJkREFLVkZLa3Rnd3dfQzJfU2E5VkpmX3lja1gyRHQ3Rjh0MHN0c1ZMbUN1VnZ0VXVpR3B1LVJWSU51N3ZEaVBOMkR0YktKWE1OYTdNeUk0?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNVJaME52TnpCMFdXaEtjMnRNVFJDOUFSaUxBaWdCTWdZSlk1QkdxZ2c=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-02-09T08:00:00.000Z",
    "time": "Feb 9",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy",
    "link": "https://news.google.com/read/CBMisgFBVV95cUxOUWFNcmhWYThEaGJ1SGYtTGpvRlNJNVRHOEsyMU1uM0p3SFdUNkpQa0lLb0VqWEdfdkJUTjJURklkMGw0UDMwMlBac2JwbE1fSkpQdGpyMzhOLTQ1bU1aZFgzWXlRU3BpeGJmRDVyV29oSGNsdUV4QnVFYTJMZ1ZkN0x0RlpaYUk3TWZQQ1FwdDdoM1EzS0x1T1ZQaC12eEY2Zm8xUUh3LXdkcnpEZlpRc2Jn?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXNkblo2ZVRRM1pHaElSblZ1VFJDMkFSaVZBaWdCTWdhMWtZb1NzUVE=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-06-14T07:00:00.000Z",
    "time": "Jun 14",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk's Wegovy bonanza looms large in Denmark",
    "link": "https://news.google.com/read/CBMivAFBVV95cUxNZV9ScU04VXZNMW5SRkFnYWV5N3NyVDZZYi1ndEVqemxzSm5ZWm9jRzFrQ0ZWUkFHQ1RhdlNyQXhvUGZvSHYtak1xd2hnRkVReTNBQXBGU1pWSnp0aE5ReFBWOVhFbElwWGp2cVlwTzhpVjFWcXl2ZnpCSEljNUpLalNPbTdGRDRUZXFPZk5FWm10dlY0ejZ1aTh4MFd0a1Roby1MM04ydE5fdGRpYTVQZHRCTXQ2N1diMWVMMw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNXdTSGhrTVZWSlVUSmpWbXBtVFJDM0FSaVRBaWdCTWdNQmtBWQ=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2023-10-05T07:00:00.000Z",
    "time": "Oct 5, 2023",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk's Wegovy weight-loss drug approved in China",
    "link": "https://news.google.com/read/CBMi3AFBVV95cUxNTnZrblBaUVZNRzJ2MnZHbWVGMTBMbW9Xb1pHeGdvOS1TODhKaWF4YjduaHFHZUlFUmN2dHVaS1AzZF9WYUQxcmVwTDdVdjN4cTJNLTZpWEFIejcya1JlYXVwbEpRMU81MEdudGhaLVdNaDUxbXNaOG1hNEJaNWlGRk5yVGFKZ0NZY1dJQ0VFLUtna1RoSUR1QWszVTZQazlJZGJveldTR3VwQS1NbENHUnZEQjBTdnJ5RzYtMngwUkRNNXZXcWVEbjJoSWpkeWhNbHJYdE5CVVpURnJW?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iI0NnNVdjbUV6UmtSVk1sZE9jVTVVVFJDM0FSaVRBaWdCTWdB=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-06-25T07:00:00.000Z",
    "time": "Jun 25",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk Smashes Past $500 Billion Value on Wegovy Frenzy",
    "link": "https://news.google.com/read/CBMisAFBVV95cUxPRDVHZ3BGY2R6M2N6RWdWeG1mMGU2aWV3emlTTldDT3BRR256ZkgtUDNPdlRoZ1pZVU1QYnJPWEd1bFFfNW1tY01PU19OQkoxVGo3N05sUDJoMFdxVTRweURUVXl6cV9waDE2eklleS1pSVNVcTgtN2NpXzA5MVQyUktiaTFzMkUwbnV0c3hmd1BPeVFkUF9KbzJkNmktOEc0WE5YdVYyZUVLZmcxOWw0bA?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNVJRMG94Ym5sc2ExRmhXbU5tVFJEQ0FSaURBaWdCTWdZVlU0Q3NMUVU=-w400-h224-p-df-rw",
    "source": "Bloomberg",
    "datetime": "2024-01-31T08:00:00.000Z",
    "time": "Jan 31",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk-owner to expand in India this year",
    "link": "https://news.google.com/read/CBMiswFBVV95cUxPa2dXbW5zUEVBdHFabUxZd0Q0QVdaWjBNV1M3NF9sTVpvZWZScDZHSGVyOVlzX2k3dFROX0tTRG9vdEFzRDVId1oyaGMxRWo0THB3cjRFZG4tbzJ2VWtHM3Q1TzVfSERrYlZEbDJfLVBBU1dndV9adkJrVkhMaXp0MjJwUzhqVFR1czF5TXVEeWJtVFlGd28wM3kzRk9lWDAzRzAyNzdmOUJ3ZVEtMzBRVldBbw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHpia1pzWDA5WGFYZDFVMlI1VFJDMEFSaVpBaWdCTWdZSmNZclhyQWM=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-03-12T07:00:00.000Z",
    "time": "Mar 12",
    "articleType": "regular"
  },
  {
    "title": "Ozempic Maker Novo Nordisk Beats Profit Forecasts As Weight-Loss Sales Soar",
    "link": "https://news.google.com/read/CBMiswFBVV95cUxObDdpMUJfX3dKdUw2bkQzclMwRlpVRGgyaWFPdGY4aUxSdnY0VzNCY2RSZTc0S0lkWjN4Vzg3bDQwZ0JKYXpIT0dHdXBDXzMwVUxFbjVTX1RBV0NfdGQxNDdyUEZadnZpb2c1ZmJwSTJnVEdWWFpQR1NlV2ptODhJdUJ0bHk3aXhnUk8tLU9LeVl1c1Zsb0pLRU1YbHNzSHdueTZ0Um9iVy1JWU94bXBoTG9FWQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNUVNV3R6UkRCekxVMVZiRmxKVFJDb0FSaXNBaWdCTWdhZFU0cHNLUVU=-w400-h224-p-df-rw",
    "source": "Forbes",
    "datetime": "2024-01-31T08:00:00.000Z",
    "time": "Jan 31",
    "articleType": "regular"
  },
  {
    "title": "Ozempic or Tesla? Markets are in no doubt which is hotter",
    "link": "https://news.google.com/read/CBMiigFBVV95cUxObUczbi1HX1RBX2tkMW9pc1dFZm4xU3pjYjUtUXFyVnVYbnQ1WV9SUmlGUW56VnZOM1NWcEZsTFJPMnBydFZ5Mm92eHZhdktHT1EyZ3lkN04xSTRSeUVjQVVhczRiZkx5dlFkS3FQVzI1TzN1Z2h6ZTVvWXcxaDlvMGJVYXdMT2UzZWfSAYABQVVfeXFMUF9LVXpsVjBnakxkRTRJS2hKS0dXTUV3UEZudDI4TDlrSHl5cmVrN2ctNU1nRi1ScWZuTjhTTFZobFFLWGZlSF9DaWNvWVZLeDZ4SkxxamdxNlotdUhJN3J1eUZtMC1LT1VKSmRWbEJncFZ1XzdSVTBkYnFSRUJEckE?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXpVak5XUlhST01HTkdWRWRNVFJDb0FSaXJBaWdCTWdZQmNaYTFLQWM=-w400-h224-p-df-rw",
    "source": "CNN",
    "datetime": "2024-03-08T08:00:00.000Z",
    "time": "Mar 8",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk tackles harm from Ozempic fakes with global authorities",
    "link": "https://news.google.com/read/CBMi3wFBVV95cUxNSjdJRlVUc3M3TVpRcnZTMm05eVdMOXltbDlJajBLZk9EUjRJLVd4MlhNQWhrQ0VvWmRvVm1XcTBCQ2E3Nl9DZlZtVHYzSXFhR1dQZVI2QjY0cHpoanRLWHZnRk5FdWhiNXl1UGRVRU9aNndNYW1KSndFdUVxYzBCUXpzcFQyWjctc0JYYTM4ZmRqWEZaVTdYVHk3Zm1fdTVjOGdKOTRVOHdaR2ZXb0haZEJ5ZXJpUTdIYkhXMVN0ODVIRHhHcXhkWnVvLUI1YTNuaG1WUFIzX1NQRnBnRjNn?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNTZTV2hVY0RoRVMzcFBTMU5DVFJDM0FSaVRBaWdCTWdhTm9aRHVPQWM=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-03-08T08:00:00.000Z",
    "time": "Mar 8",
    "articleType": "regular"
  },
  {
    "title": "US FTC seeks more information on Novo Nordisk parent-Catalent deal",
    "link": "https://news.google.com/read/CBMiswFBVV95cUxOUVhuOWRPcm5Bb2RhRV9JWlZ0SThrcmtsNjVDcm54UGRFNlN2QlRoTWExVjZMR3ZwT3JBQUIwZ3BPUXI4bkVQSl9PNk5zRWZPcVZhamRlQXBleW1USFpVbG5uc1J4NnA1UXJmTTBKdmVxLXZsUDNjRjFrQTIxdzBaU3NIMk1rUEloV3NVVG5KRGd0R1lTTVNkeFRsaXVpQWY3OFc1VEgyMm1zUUZTXzhJaUVSSQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXhhRkphY0VaV2FqWnBWazQ1VFJDMUFSaVhBaWdCTWdhSmdKTEpPQWM=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-05-03T07:00:00.000Z",
    "time": "May 3",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk is optimistic that Kalundborg fire won't delay expansion",
    "link": "https://news.google.com/read/CBMiqgFBVV95cUxNeERzbnVCdF82azJpeXNydkZvRVQwMGc4Y1F0OVZGY2RNS3NBQlhEbE9xR2V2TlRNdnk2Zm5aelM5VXNndjNIbFViYjBuY1ZvU2hUczI2SGpvV2xOeFNnOXZOdXBWc2hpcmZQOXc4eEZnZ3RSX3BvYjlfWnk5S0JyUS0ycFpXT25XY1JpdkJ4TUZ1R0JzSWluVzBGY0l3NEM0NVhvWm9RVHZ0UQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iL0NnNHhWbUZIV2tSNFQwRnljSE40VFJEaEFSamhBU2dCTWdrQlpJWkhOcVY3RXdF=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-05-16T07:00:00.000Z",
    "time": "May 16",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data",
    "link": "https://news.google.com/read/CBMi1gFBVV95cUxNTF9zRnVsZktSeXdERXVnTElrRndZYUpZa213clZ5M1czRlNWQ0hRNzNWdGc1WXl1bW02Snlfa3k2X0YtQTlrcVBGbHBpb0VQbHdlSmx5N1NzVFdxbXFBVVlpRGFoa3JCazVIa1pwQmU4OFFuM0M2TnJHeXJIdkNfVlZ1bVFUaDNoZnIxazBjeVZNS1hGdGhxaDE2MVhaTktVd2ExYWdtdWFRNTZxaG1NQTNPVm9pWGxoYjh3cHVYQ09NajlrUlRXd2ZpdjR1S25tX3RoMVl3?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWZXVlJKYTFsQk9XZzBXWHB5VFJDMkFSaVZBaWdCTWdhMWtZb1NzUVE=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-05-03T07:00:00.000Z",
    "time": "May 3",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk shares dip as Wegovy maker posts earnings miss, cuts operating profit outlook",
    "link": "https://news.google.com/read/CBMic0FVX3lxTE9fOHZUM3hKaC13d2hnSW5FSzQ1bTRXNW1IRDJTU1lncFdMWGNaUC1UdVdZYmdEdjNsLU56NHBPQlhTTU9tUjBPUF9zYmliSkhOc2VfdTZWWDBIMUM5SW8zQjFIMnBUaEpiNER6em1uaUctdHfSAXhBVV95cUxPTDF5UjYtejUtYnh0cWNNTVRsS0xUWjBwUFUyZzB6S2RXNlRLT3NJQnJyc3BwbG5CQ1Z6YzVCWXZBejVOSHdFZGtKRVJUelkwWFZOVHJ1Vnp1Y1NuOGs3UjhVci00N242cklUeWJUMkV4MS15WEwwczg?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iL0NnNVdWbmd5VG5CTk9XNXJRWFpHVFJDb0FSaXNBaWdCTWdrbEVwYk5LV2M5eFFJ=-w400-h224-p-df-rw",
    "source": "CNBC",
    "datetime": "2024-08-07T05:48:07.000Z",
    "time": "4 days ago",
    "articleType": "regular"
  },
  {
    "title": "Novo invests $6 billion in Wegovy production, still below demand",
    "link": "https://news.google.com/read/CBMitwFBVV95cUxNRGhIaDhlWTVZWXFUbkFCUm5MWjdFaDktZEpUMm1TLTdFWm5PbThfeHBDczVUYUtEbzk3WHYwcWpGc2RGbVlBTlZCMnZfdlRVcXYwWUNZWC15UmY1U3d3TUdESF9pZ3B3dVY5S3VHSU1ycC1vLTM3bDdqajJULW5ZaWdnUHJid0RROTRHVmNRTGxpYlBpZnVsVlBkZk9hU0tmRmhHbUZocGRBQkhMck0zZjJSUGw2WlE?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWxWRWczTWxwMVJuVmFjV2c1VFJDLUFSaUpBaWdCTWdhWlFvaHJPUVU=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2023-11-10T08:00:00.000Z",
    "time": "Nov 10, 2023",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk expansion with 1,000 jobs touted as biggest life science investment in NC",
    "link": "https://news.google.com/read/CBMiwgFBVV95cUxNYmlrWnBhTV91ZEd1WUsxOGdTeFVUVG9rWlRhSnUtbmFCdEVNY1ZsTGtqYlBUX2VlUXZZQ3hDUjlRSzd1X19fay1vcXg5SnRjLXpoWVdwb1N4Y0VMM0lrNzFBdmlWV1VoT1U2YUNlOEh0TnVjRXpsVlNaTzE4N2xrMGViMFUyNDllbHRuNEh4WXA2R2JTU1Z3MWoxT2JvMXhNVHZlZkowTmZNczZrTFlnWWUwZ0FuM3dFMUpNOGxDTUV5QQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNVJORkZHZGkxYVRrSndiVzQzVFJDb0FSaXNBaWdCTWdNaHNBZw=-w400-h224-p-df-rw",
    "source": "Carolina Public Press",
    "datetime": "2024-07-08T07:00:00.000Z",
    "time": "Jul 8",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies",
    "link": "https://news.google.com/read/CBMi3gFBVV95cUxNOWhEaDV5S3g5V3N6ZUN2UVVpN3IwQWg5MFFtckhqS1VLVHV0SWhmWThNQ213Z19jNG83Q3hwYkRncEN4MDBDWXlVZ2FzdjRvdGRhX0EtUXhvaUNmbTNlWkJFclZlb0dsVUJmcVByR21IbUIzeWRMVlBVdlAwRjlpTzRVcnZuandUSGRXVXZ0M2lGZXVoVjlzWWFLczJSUng1VnN6eTV2NUxWZFN1VVFNRGdvUlNYbmEzd2drOHBXYTVSU1dPNEk3RnpickNENV8wN2JOTktFSGtHUXQtaXc?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNURaVTlVVTFrMFowaFNiMGxyVFJDaUFSaTNBaWdCTWdNVkF3SQ=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2023-11-30T08:00:00.000Z",
    "time": "Nov 30, 2023",
    "articleType": "regular"
  },
  {
    "title": "WHO issues warnings on fake copies of Novo Nordisk's weight-loss drugs",
    "link": "https://news.google.com/read/CBMixwFBVV95cUxOeTZObEhCMjRrZWgxUGJwSW5weW11MGNIQUJjTFYwc1hTTUtmdmxqTFoxMjAzcFNxZ08zamJQX1NGOFRSRWZxUi12aHJZQTJNMFBRNVM4aW9seE5Mc2Z4VEtsTWs4SVhFaEtsSkFic3U3WkROZWhSeFd6SDZQOGxyTnhMZS1yVUljbW5NNjFwdHBPZG9SajlyaGcteHM1NEhBUk5Xb3BQdWJyUEVnMTRrSjVxZWpYREV0bHo2dEFBbDhHSzlpd013?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXZkMGxCVjBScFdISXRPREZKVFJDOUFSaUxBaWdCTWdZSlk1QW1xZ2c=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-06-20T07:00:00.000Z",
    "time": "Jun 20",
    "articleType": "regular"
  },
  {
    "title": "Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing",
    "link": "https://news.google.com/read/CBMizgFBVV95cUxOZGtKSTBTUklUT05kbV9WYnRDVnk0bFBEWlhxRkRheFI0anl6Ukc2d1U5WmpJa0ludWh4SlBBcFc3a2J5RklSM0xMVkpFRHR2ZmJhRi1aX3JtSTZWcGZtbVVGUnE4U0laU19BRVhDLUhqWVhWN25oTE81aTAxWlJWOERERDdMbE55ZnNLbjlUOVlUUEpqY0ZTWUZadEVOVXlvbTNzRFZDRGhZd0dwNEJhQnd1U3F4OFFmS1hXSFdfdXdFeXdaWjJuRkl2bHBGZw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNVVkMjVNTFdadWJYZENaVGhCVFJDM0FSaVRBaWdCTWdZaE1wUU9KUWM=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-06-24T07:00:00.000Z",
    "time": "Jun 24",
    "articleType": "regular"
  },
  {
    "title": "Novo valuation surpasses Tesla on experimental obesity drug data",
    "link": "https://news.google.com/read/CBMi5AFBVV95cUxOYXhVdHZqUmEwT0pVVlNlQV82U3habDlyT1dESXNlRzdtRFZsdFYxNmJBVExUTDdBbXljSGRpLXZlYTNuUmRPVXhTdDM1YTFYTmlNZnNIWVpTVWZmMmpod3JmV1FqZkxwWWpJaDdoNXRUMlJEc0hpUUN6bXBUN1dJbVBBMndCSTE2MHJUSjJGdVFVcmQzNmk2ZlRKWlFzVUVGVkNNczJFUDNjNDV1ZTdfVkh6Tkd5cVAxdG5mQ2d3TS1DajVSN3o1b0ZCeVpPR2VUSFlaQ3Q4TnpFUGZaVkdfWEU5R08?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNWZWMDFwUlhOb2MxSnZaRkZ0VFJEN0FSakpBU2dCTWdNZFlBNA=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-03-07T08:00:00.000Z",
    "time": "Mar 7",
    "articleType": "regular"
  },
  {
    "title": "Ozempic Sales Up 58% As Drugmaker Novo Nordisk Nets Record Profits",
    "link": "https://news.google.com/read/CBMitwFBVV95cUxQU29MZmRxcU1Nd05lU1lUcllWeWZNT1U4by1Eb2RlcGV2NDh1UHdmTDg5SzNydFVTYmtXNWs0V2dGOGVveVJ5LVMxQ0lOTmgyNF9hQWViTl9kRmU3MVRRTk1FZTJNSUc0UlFmQzdFb05lZGFzMWFPZG0wakVpUnBkdmk4R2szQTJrS1dUQUpLbF91cEtCbmhucVNkNW5Hb1h6cHVNNURuSVVWNjEzTERnb0VFUWthZkE?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNTZlSFpGVXpsNmNYVjRaSFJ5VFJDb0FSaXJBaWdCTWdhaG9Zd3RPUVk=-w400-h224-p-df-rw",
    "source": "Forbes",
    "datetime": "2023-11-02T07:00:00.000Z",
    "time": "Nov 2, 2023",
    "articleType": "regular"
  },
  {
    "title": "US FDA staff flags risk of low blood sugar for Novo Nordisk's weekly insulin",
    "link": "https://news.google.com/read/CBMi1wFBVV95cUxNMUFadWtva25XRElsSVRJVDdNQ1RvNXk0RGxUWVcydHJaaHJZY21TUHRocjUyM3ZVNjJmaFZQN1ZraXRDdXJrTjA4RjBSOGl5YUtVdUk3eEtSX21rWlZvTVJRYUtFX1ozUFdsNk1ObmhCVUFtcThKLXljT0d0SGlVLTRqSHo4a09FVlFpa1ZjamctTFNtQ2R1WXBNWEhEeTBQRVV5QXNveU9iN3hwMGNOQVZma1Q0ZmhNa2hFMlU2SDJ1bjlxaWxVcTNsTEpsSzZhTXVlV0N1MA?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iL0NnNTNjMnhHUWtSNVRWVkxYM0UzVFJEQkFSaUZBaWdCTWdtSmNvaUlNU1pVRkFF=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-05-22T07:00:00.000Z",
    "time": "May 22",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk ties up with Metaphore to develop new obesity drugs",
    "link": "https://news.google.com/read/CBMi2AFBVV95cUxPbGVSU0hhMUVnNXlpSS11UHljUHlLRzhVZHFsN2NrM2hQcHFpVjUzVnVOTEIyMXU5YjlSaGhJZHEwOXhzUFJzQXhNNmpTamotMGxYNy1SeGxncUNXRDFxTjk5UEkzUXpqNGd5SkVXOXp0elhIcjAwYWdSdC15YWRfM3gyMnRuOGxndjZVYklZYnRqRW8zMDl5bDFmdlRCTzZHdmRCcjFGM0JGMklETHk4OFpWaEdXd2VSSHAxN1Nyb0xINlJlTlZpeWw5UWVGN1lqQ01IVVFwazE?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNVhjVlpUVTBwWFNXcFdUVkpPVFJEQ0FSaUVBaWdCTWdhQkVJUWdRZ00=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-05-09T07:00:00.000Z",
    "time": "May 9",
    "articleType": "regular"
  },
  {
    "title": "Denmark Is Hooked on Novo Nordisk's Success",
    "link": "https://news.google.com/read/CBMingFBVV95cUxQR2VjNmVZQmc1T3JQbC1kcUZ0ekNPT1cybTNpSG8xWndqaUZBcjRQZDNSdXB5Z0hOUlRuc09aTEZGeUJYd0VWRUFIdExGdm1WZlVycTNiLWxQdWxKVjF4ZzZIS3RKcFc1RTRKYkFhX3ptQ3VNRzJTY2N4TmJVVU5lQzkxdzliVEwxYkN3dVFKSzV2UUx5REpQRzdKb3kxUQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNTBORUo0ZVV0ZlFXOUZka2wzVFJDbUFSaXZBaWdCTWdZcE00YXZOUVU=-w400-h224-p-df-rw",
    "source": "Bloomberg",
    "datetime": "2024-05-01T07:00:00.000Z",
    "time": "May 1",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk confident of amycretin obesity drug launch this decade",
    "link": "https://news.google.com/read/CBMi2gFBVV95cUxPejU3VFhMMWtZZVZFd1IzMWVUeFFqVmNwNEZXTWNqTUtneEFsclNiRTdmWGw4TjQwTnlBNkJ5LTJ5TkJvLVBMdWNlZTNXbklzMFQyRTNxTkpJTWx1cFdaYUpzT3BMb2dNdHZ2YUxVRzFiNlN4X2JLUThKRFlFUzlhbjNCcTNqN0xtQXBHbnZTYm43RVl5ZjVWQ241R1JmX1VYeEVqVmpaVExnaXJPaUJhRDNZUXNncDJ6SWhrTXB2LWc3ZUw1Yzl3R0pBSDBGUndsV1B2R3dwdkVudw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWtkRUZCUkdSNE0wMHlaVmw2VFJDM0FSaVRBaWdCTWdhdGM0aHdPUVU=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-03-08T08:00:00.000Z",
    "time": "Mar 8",
    "articleType": "regular"
  },
  {
    "title": "Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk",
    "link": "https://news.google.com/read/CBMixgFBVV95cUxPOXZmNld5NXU4eTVNc25ZWERnMzlvdkVrNW8zd2tZQTh6U1IwMW5sZC1TNkVmRzFYc1dsbVp5cmtfdjN6TDd0XzVWendZdWV3Vm9uVGVicVF6OW5Hejl1MXFOLTZlSXVMUFUxTkxLTDI1cmcyc0EzM3Q3ZzZrZVNKbGhJWXJ1Y1EtQW1nTDZBNDNjTWZhZzZ0X0dSWjFDWTJTbDJvQnZ3MGJIWTgtRWsxTHQxcG9IMGh1RnJzcVNWVGVoei1lMXc?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJkNnNVNURUl6VUZjNGFuQnNYemM0VFJCeEdMMERLQUV5QXdHQUVn=-w400-h224-p-df-rw",
    "source": "PR Newswire",
    "datetime": "2024-05-02T07:00:00.000Z",
    "time": "May 2",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordiskâ€™s growth plan",
    "link": "https://news.google.com/read/CBMimgFBVV95cUxPTVdsQ0x2dmlSYUJwUml4bjg5NTl3VzJyME1jUGl1WGJGTlRRUGxPcU9YTWhtSmxOeWdUZzM1Y1RKRDRoZkZpUHVaNThtTGFXUkpXNjBFOUU1U3F5RmxEUXNfLW9oQzhlVzIwcnBhOVVINThWYU9YaE9uV3FUa29WMDludWpsODg3N0xqSy15aWU3eEtEU2JjMF93?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWhkVXhLV1U0ek5qTlZUMmxQVFJEaEFSamhBU2dCTWdhMWNaVFJMQWM=-w400-h224-p-df-rw",
    "source": "STAT",
    "datetime": "2024-04-22T07:00:00.000Z",
    "time": "Apr 22",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordiskâ€™s weekly insulin rejected by FDA | STAT",
    "link": "https://news.google.com/read/CBMihAFBVV95cUxPY2pQajZkYkIyZjlMdGlmQnVmOVJrVGJwb1BBdFFiZHFwdGlSYzFTLVNLSW93elVjQ0RiQ2NQeWZyTGUzdlY1aXUyZkRQaUsySVd2cGJyeUF4MktxX1AyZEZRSWNuOTZnMUtXWXQxWm40bE84YmV2d2ZWVnUxZUo2MHViSHM?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWhkVXhLV1U0ek5qTlZUMmxQVFJEaEFSamhBU2dCTWdhMWNaVFJMQWM=-w400-h224-p-df-rw",
    "source": "STAT",
    "datetime": "2024-07-10T07:00:00.000Z",
    "time": "Jul 10",
    "articleType": "regular"
  },
  {
    "title": "Ozempic maker Novo Nordisk invests $4bn to meet US â€˜skinny jabâ€™ demand",
    "link": "https://news.google.com/read/CBMipAFBVV95cUxNbVNCZXNzdkFxX016aGc3VjB4c25EOW45Wkk1d1VKVFZBdmdZaV9HSjlaYWc0M2dBeWdnV3piRTVTODJpWExIWXcxQUdtMVdUaEQ5YlJSNzkwNTZpYnVOdWhNVExlNnBkVmNzLThiTWtSNXJFVEM2R01iRUExYlh3RC15dXNXTjlfWVZYYUpuZHNnTHdBZnpFc01uQ2ZNU01mNjQyMNIBpAFBVV95cUxOZ1lQZktLMWJTMVZEWjFuR09GZG5IdlpJZEpER01tc2hVbXlTZ0d5aVZpLU9aLTA0UGk0Y3JRQUpiRmlEMmNaa0VHdjBVTWpHemFBMDNONzBuT2lTamhnZU84ZndYSm5FSjZCRGhvM193NWprRi0yZm5oQ3hTWVBpMzFLN0ppV05Za1c4ZlFZejVpRG5kZjQwNHNNLXlJNmJtM1Q3UQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNDFSeTFYYkVweVgybHFlR3BQVFJDakFSaTJBaWdCTWdZQm9ZSzI1QUU=-w400-h224-p-df-rw",
    "source": "The Guardian",
    "datetime": "2024-06-25T07:00:00.000Z",
    "time": "Jun 25",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk ends kidney disease trial, books $816 mln impairment in Q2",
    "link": "https://news.google.com/read/CBMiuAFBVV95cUxNZHBBZjRVc1hva2tlakR4Z2F0cjBNczZiWmxWM3FZWXJZdDR3bmtnbXJSM19wamVYb2VGZ1hzb2VEeTMwalhkMVlKbm5xcTVXS0VpRDJZbW8zX2NSSWNrVGxqeHd4Slh1VmxlcU1wTWt2ako2ZmhyNG5hLXRHaHMwSzAxZ3hISEdfRGhFRU9TUEJkbFpZRmdfQnlLbnNoYWN0SVNNS1ZITUxBS1VsNWc2eGNuLXFyUUxI?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXNkblo2ZVRRM1pHaElSblZ1VFJDMkFSaVZBaWdCTWdhMWtZb1NzUVE=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-06-26T07:00:00.000Z",
    "time": "Jun 26",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double",
    "link": "https://news.google.com/read/CBMikAFBVV95cUxPR2tiVHNRc0NCeUNTX205c1V4dHZ6d05tYy1SeVRXUXlQdFlESDVIakdXbnVZbWtlc1BfV3N6SGlPQTB1Z1dPS1RibFh0dWZ6MlI5bzl3Q2tXZzdWZHoyd19NUTBzUVBVdHljX3pqWG9IVy1MYjBIYTljNGNuZ0NkeEJJUjhMdy0xSzlWOE90NFXSAZYBQVVfeXFMTnhIWUZ4a3NQN2k5YjVfMXlFc01VU1N1U2lVN0ppLUhzWHZRTGNjUDJsdVM3bkVINDJuWHpBZWJOYXZJZkV2MzZrYmNuVC1tLWQwYmlTWFZSVnhHalZIRk0xMlh2NFFOWFJ2OTdUWmxtV2ttbjg5aElCRzRNaGlhcklBRUQwX1M5ZlkzaGFpeVpSNUZjdXR3?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXNTVVZyV0hRNFozaEZWM0YxVFJDb0FSaXNBaWdCTWdZVk1KeUhIZ28=-w400-h224-p-df-rw",
    "source": "CNBC",
    "datetime": "2024-05-02T07:00:00.000Z",
    "time": "May 2",
    "articleType": "regular"
  },
  {
    "title": "US patients take Wegovy obesity drug for around six months, Novo Nordisk says",
    "link": "https://news.google.com/read/CBMi4AFBVV95cUxQTFFzYTlkM3h0ejBTdXdOTE9GMFhFX0wwTWRuQ2wydS1udHRablVTMFRtRWdEWmUzaE1qZk5ILUVSUUR3dFhTblE4VFFzSjVxZTRMTEwwc0s2RW93dWFzM3lsUVlPTXpHcTRESkRIVVlNVmNocmxtNWhVV3ZvcGZtRk16ZWlnTE1oQWx1TVRHdnhlR1A4d1hxakRnaXpqR3VYNUsxcEkxT2F3R29nZFcyUmx0ZjY0MXg3QnMyR3N0THl5UGZZY3AxbVUyeVgtTEx6SUdtX0p1YngyZ2ttdDVkeQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHdVMkpVUmpGUVUxaGxiMDVEVFJDM0FSaVRBaWdCTWdZSlpwTEZLZ2c=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-08-07T12:58:00.000Z",
    "time": "4 days ago",
    "articleType": "regular"
  },
  {
    "title": "Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5",
    "link": "https://news.google.com/read/CBMi3gFBVV95cUxQZ3gyRnhJZW80WXdlQ0JYSXEzaXNXUWtWUXFiWmlNOWlJQ29pYkJBLVhMMHJZY3J2NEJhUk9jMi1nMHNyYmd1elozR1pycWFsNjJfaXRGaDl0RkNReHNnVlFMRW5lU0d4V0xreFA0OGZlbnZXTkNlMlUxZkZIMzhiN3RMNlpneC1rWjVvc0NwRVRyTkFpMGlBUFBjR084YUQ1UE5la1lrQTFKRjZXZVBnTnRHTVRhbDJlV3IzV0hsblBESDc1TEc0YWZWTDhFRlNKYXI1czk5blQya0FIaFE?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNTBaRTFuZURGaloyODJiR2R1VFJDM0FSaVRBaWdCTWdiQmNvNFRMUWM=-w400-h224-p-df-rw",
    "source": "Fortune",
    "datetime": "2024-03-28T07:00:00.000Z",
    "time": "Mar 28",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk wants to be a cardiovascular company, too, with sights set on inflammation",
    "link": "https://news.google.com/read/CBMimgFBVV95cUxPbS10ZEhJSkNWNXZKSXpLWm1CbkhvS1RQemgyNmRuaWRxNzQ1NF9zdDVCMVNWQjZqS0pMblNJOENuM2k5VUs2ckNRUmxyWEZSb3pyU3l1NFpUMW9HZWxVTW5XRjdFRl9jc2tqaW0yd0EwTlFPY1ctTEg4YUljT00yQkZfVlRDUjJsS3NGZno3eWxQUDAyaXJDS0J3?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNVpMV3hFYW1VelkyWXlSM295VFJEaEFSamhBU2dCTWdhZFE1QnVKUWc=-w400-h224-p-df-rw",
    "source": "STAT",
    "datetime": "2023-11-13T08:00:00.000Z",
    "time": "Nov 13, 2023",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk flags big 2024 sales boost despite Wegovy curbs",
    "link": "https://news.google.com/read/CBMiyAFBVV95cUxQUldNRVhwLW82OGNXQXNpaXhtS0JkSldFSHc4V0dQcTZGTFBRS0RiMUlpWGI1OFBFZVhpNVBwWXBfZTFQaS1ZODFMUV8wT04za0NIcmZpQW40aThhYkx1M2hCN2tZMVJHWGNiZ0dnNmhMVDVTZUFZMXpBZlhKSTdEZUF5bG42bFN4U2tZcTA1RG1GYjhBODluQlJVTXZDbTZURGlFQVJsNDB2LWk2cmFlTXB6eTRoTkFNYlUwalFRZkJ4N3BJYlc5Rg?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXNXRTAwTjBkbVkwSkJhbEJUVFJDNkFSaVBBaWdCTWdZaFpJeHRKUWc=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2023-11-02T07:00:00.000Z",
    "time": "Nov 2, 2023",
    "articleType": "regular"
  },
  {
    "title": "As GLP-1 sales surge, insulin users fear Novo Nordisk and Eli Lilly will move on without them",
    "link": "https://news.google.com/read/CBMijAFBVV95cUxPQW1vUVphT2VWb19JTUtiVm0tVldsZjVfQ2wwQmprU2prR0pJUU9OSkZKSEJoRmY1NzNnbGc3ZjVia0lWZmd2LXVRX1F4ZVR0cHU2VEZJbzhDUmp2U1BEV3ZpZmNqa0hKd0Q5SGcyUGlnZTNtT3p3T24ybHBpaEF0aXFjeTRBZ0h2eVpjQw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXlURmsyTFhOUlpFSnlaRlkxVFJEaEFSamhBU2dCTWdhdEU0eXVFUW8=-w400-h224-p-df-rw",
    "source": "STAT",
    "datetime": "2024-07-17T07:00:00.000Z",
    "time": "Jul 17",
    "articleType": "regular"
  },
  {
    "title": "Wegovy users keep weight off for four years, Novo Nordisk study says",
    "link": "https://news.google.com/read/CBMi0AFBVV95cUxPc2duNm8wRU5fRWV0bUNabHc3MHBBckJkSjJEZmlBZWhoenB4QlZ0U1J0N25jNkdzRFROelEwV0hxWmNQQWpQd3NlZDNhXzdJakp1M2gyaEhYdVhORXl1SG1pYlV6enk1a2RyaHhteW50eU5BYlpOeWtpWGwwVWNTMmt3MkR4dUx1N2M3bEphUktiNk9kdzljdGx6cHJpZnB5VjliOHJUV213bzlRcE91Z18yOFdXZ2wySTBBOWtjMVE3Uk9ia1VRYmZZSkVYM05N?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNW5NRkF5U0ZnMVNVRk1TVXR3VFJDM0FSaVRBaWdCTWdhTm9aRHVOQWM=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-05-14T07:00:00.000Z",
    "time": "May 14",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk's controlling shareholder plans to invest about $35 bln by 2030",
    "link": "https://news.google.com/read/CBMi4AFBVV95cUxQRmxreVlHaGJhbjRjQjJEN3ZQbjd6Njg3SVNubmZBUGE3TEh1YTdieDQwTndKdTFTMU5DNy1IbTRhYnFscDB6U0tQQjBFXzltQm1obmRwV1hUdTRMNl9ldFpiMi00VEJ3RVVpTXFqVE9rb0tjUWFDZENjQi1JVDNsRExWU0xfby1kUUp5TEpac0tKRjZwNnFWRlJPNVBZeUV3RHA5N0NKQnRPb3lTV2xzN1lRaGtaLXZNX3FIY1JzY3VZZWZ0THM4SzRqY2x0WV93cjVESlkxOFgzUm12Z1pHWg?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNXBlRVV6UlRCb1psVnlTMjQzVFJDOUFSaUxBaWdCTWdPVkFRSQ=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-02-12T08:00:00.000Z",
    "time": "Feb 12",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk's market value of $570 billion is now bigger than the entire Danish economyâ€”creating a 'Nokia risk' for Denmark",
    "link": "https://news.google.com/read/CBMisAFBVV95cUxPM3B0dV9KcU5zandjbWRfcXBRRGFkbXFNa0U4REtNZEZkbnA3V3M1cDM2c05PWEdadXI5WklTbW1zOEZEd2ozcWtqdVp0bG01MnNXOFJrckIwMTVMcTBtV25qRWVJYm1reDBsdjV4bzJWeHI4aFZBWVpuWHhITHRNWUNZWEkwNC1MTnNUZFR6dmU2UmI2ZzZCUThRYmFLaWY1eU5XTGF3R3N4aVJSZUNnUw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlZMjlXY0VKVFptbzBjRmRsVFJDM0FSaVRBaWdCTWdZOUU0UlNGUW8=-w400-h224-p-df-rw",
    "source": "Fortune",
    "datetime": "2024-05-01T07:00:00.000Z",
    "time": "May 1",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk expects double-digit growth as it boosts Wegovy supplies",
    "link": "https://news.google.com/read/CBMi3wFBVV95cUxPSExHT2VzdVNpUER3MVl6SkFzRzI0RFA2NXRyNkRNX1JkdkU0eV9CazROanFLdzJLaXhXNmhWZjhNcTVtazFxQjVyam5yQllva09JenRkdmFIRTE1UWQ2ckJjbjFSMDZyMmFXTE9vSlBOV01ORVpWV0lqSTFMVWJ3cnM4QURBazFVbDZ1M1RObDNjNU00R2JOcDc0MzNVTUlzaHZvSWhreFFkNE9TSnEtalB4WHZ1YllfSEdvUlk2NFNyaUxEcjBzemhRWkR2WjR0NlZ3Y2UySXp4N1pqY0tJ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNVdWRUpsTm5ZNWVreFVXRmx1VFJERkFSaUFBaWdCTWdZQkVJU3pPQVU=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-01-31T08:00:00.000Z",
    "time": "Jan 31",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk parent refiles US application on Catalent deal",
    "link": "https://news.google.com/read/CBMiqgFBVV95cUxPRUd1ZFEzSjVTT1JUeWw5bFlqNEZua2RSdDJWSjNaVi1jMTZyeXNqeUx1d1E2YVF3QXRGVjAweFRtRzJhVUFwaGlyRlRVOGg2YWRmWmlkZW9mdHpSX1FSUzZJVUl3UENCYWpaRzh4XzRJbVB4eGFfTzRQMFhCZWhPaHJ6MmZuTXo5NjlZN21lWTM4MjRjNDZhVjNQRm5zb2toTXg1VjF5RFA0dw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNVBWREpSVEdoV1VHNXljMm8xVFJDOEFSaU1BaWdCTWdNWnNnSQ=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-04-08T07:00:00.000Z",
    "time": "Apr 8",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk launches national WegovyÂ® campaign, Power of WegovyÂ®",
    "link": "https://news.google.com/read/CBMiugFBVV95cUxQQ1N0TWRRNXlmcHJ0TGVmcHVzc2JnRUdlZ0ZxRTlOZHNnT2lra1FzUURYVVdPVXFYbkdNU0k1RGdSbFJVRGJTZENNTjRIQmloYkxhRVEyMUpNSms1SzdiUDJWVndqdGRQZHJpbHJzak1BUTMtcW9kN2JZZlBBT016d3JEeWVIcERfYmktTC1MODJmaDFXQ0JCMFlDYlV4TF9Db2xuc3g5d2RkaXR6LTlqb2VXQTRBbnZUY2c?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iL0NnNUZWbWxCWlVaMVNrMWFVRFpQVFJDT0FSaklBU2dCTWdtUkVvRHNNV2lpcFFJ=-w400-h224-p-df-rw",
    "source": "PR Newswire",
    "datetime": "2024-06-03T07:00:00.000Z",
    "time": "Jun 3",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk passes LVMH as Europeâ€™s No. 1 stock shows weight-loss buzz",
    "link": "https://news.google.com/read/CBMixAFBVV95cUxNWnMwYlR2OWROR3U4ZHZvWVFISHlacVlmSXBxUTVxRU1aY0lDOVZaemJKZE5neUxzUWQ3WTVDVU82RlYtbmotSGtQa2sxLXlsZlhCRWRtaXRfZlowY2JSMWI2dmVLS3pSbUxmVXJFVXhCZnFZZS1vQ1kyQkszQnNuWkFCNkdEdVlQbGF5ajRFY3dEMW9idTBsd2p3UEc5V1A4bXNrZEVFeG1TUHJRdC1FRm9iUDQ1WU5NblFnaVRxS1RPZkJn?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iMkNnNDNVaTFuWTJ0emQzVmtkUzFvVFJDekFSaVpBaWdCTWdzQlFJVEZJU2d0MVhpTGln=-w400-h224-p-df-rw",
    "source": "Bloomberg",
    "datetime": "2023-09-26T07:00:00.000Z",
    "time": "Sep 26, 2023",
    "articleType": "regular"
  },
  {
    "title": "Bernie Sanders calls vote to subpoena Novo Nordisk U.S. head over Ozempic, Wegovy prices",
    "link": "https://news.google.com/read/CBMiqAFBVV95cUxNc3h1NXNCTlJ1d3FGVVp0SndUT0VIYVpMQ3VhWFJDaG1EMW80aG9sTmRaQzRTY0UzZWxFQzE2LVluWVRSZDVhd2ZjLVg4cVlSQUZlMHZiTDhNb3dCWEZZQVdnbmdXYm5Nc0w5S2lucjdEY3BNV3ZFcmdhM2FsRWlhRm1LZnhsLXB0dWE5Y3Z3eXRlbWtITGM3aHVwbVVFcVhHY28xaGNtTjk?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNXZUVzFaUlVSU2J6WTNibTFEVFJEaEFSamhBU2dCTWdNUllBZw=-w400-h224-p-df-rw",
    "source": "STAT",
    "datetime": "2024-06-11T07:00:00.000Z",
    "time": "Jun 11",
    "articleType": "regular"
  },
  {
    "title": "US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients",
    "link": "https://news.google.com/read/CBMi4AFBVV95cUxPcVpSdm0zVjB2aFduRVlua2pSbmtKQ3BzNmVtblk4Z09MLThPV3pXTGdoam1tVFg2dTN5RTB0eXUwUmtqRGpVcFRxY2gyekV5M1dVMFp5eW1mTWZwZ1d4cEVPdUxXUUtGMXJSUWJkdFJXbWQwNXRibFZHTWRscDR0NThMdktqd3VlVDN2eEJMZFRSLXZRQTdSSnFtOE5aVXFhQ2hjY0dXLXBvWnp4LUJqUEg4UjBwVWtERDJZWm40cS1ZV1RyYWx3dzFOdG9SNXczOEcxQ0ZabXNrakxmZFBwUw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iL0NnNUNSbXRqZFhWZkxVTlVkbDlLVFJDNEFSaVNBaWdCTWdrQkVJaXZPT1M0YlFF=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-05-24T07:00:00.000Z",
    "time": "May 24",
    "articleType": "regular"
  },
  {
    "title": "Hereâ€™s Why Ozempic And Mounjaro Rivals Wonâ€™t Topple Drugmakers Novo Nordisk And Eli Lilly Anytime Soon",
    "link": "https://news.google.com/read/CBMi9wFBVV95cUxNaFpkbzMwZF94bnhkcGt2NmVCTGh1cnRIa2RVaHcyNGZCYXpYSWxqOG5FZGRkTjBla2l1ZkNTRlFvWklWME1TVUtNZ1paX3FXWkIxZjNuME9VWElOTklzSEpITm51UjNZcUVtZ1ItMVFWRVJNNWtWZHIzNWlOYlNCUi1pMXkwX0l5ZzF2bWQtMzBTM2NnWkREUTJpdGNOUng0ZzZUM1RMLVg1UUlmQ0F4SFJHYkVMU1NneUxLMmx6cWVBZnY5Tk9COXFrV2MydXlZWmlydE16bEFrck1pUDVCWnNmR1lub0dJV3llb3REdmY3aldFYlRz?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNUhVekIyU1hoVmNGQlBjMlY2VFJDb0FSaXNBaWdCTWdNVkF3dw=-w400-h224-p-df-rw",
    "source": "Forbes",
    "datetime": "2024-03-27T07:00:00.000Z",
    "time": "Mar 27",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordiskâ€™s sales disappoint as bottlenecks hit boom in weight-loss drugs",
    "link": "https://news.google.com/read/CBMicEFVX3lxTE9FNVdGS0NDbFlkcVJ2RHh4LVNQRDZHZExzLXEtU05XcHBZSjdKTjNMdVRsWFlwNk9UQ0FFN0RhYURmdk02QmpWTUFfOXBKeWE0eTluTFRJc1JQN0JGczNoMThMZXhtT2ZoSVBXcEJQZDA?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNUVSRGcxVm5OZldXTXdkVWt0VFJDb0FSaXJBaWdCTWdZaE1wUVR0UWM=-w400-h224-p-df-rw",
    "source": "Financial Times",
    "datetime": "2024-08-07T06:18:32.000Z",
    "time": "4 days ago",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China",
    "link": "https://news.google.com/read/CBMiygFBVV95cUxOU2NyM0Q3cG5aY1RlQlE4VjcyajdEWjROTXU1Ull1X0lBd1o2X291ODFiUFBPY2JPREFmSUZKZUxLU0RkVnp4a0ZsSFdIZlJBejZNVUYtbHlwaWlXZHQ1ZzVQTDFHUm92R3hQYW1IeEdoaXVaaFVFXzcyNmlxd3NPb3dpTnhUSldvUTFITkhXRXlkU0hiTGNYUlVNeWUtRHVWRzVBbnI2M3l1TVI2enIyXzAxVWtOaFhwbHFIa09zU0M4S0VNNXdlU0VR?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNUliamhtTTNoQlJIbGlZbHBHVFJDM0FSaVRBaWdCTWdZaE1wVHRKQWM=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-06-06T07:00:00.000Z",
    "time": "Jun 6",
    "articleType": "regular"
  },
  {
    "title": "The Secret Ozempic Recipe Behind Novoâ€™s Race to Boost Supplies",
    "link": "https://news.google.com/read/CBMitwFBVV95cUxPd3BjVW5GcEZ4SnVRaVBzazBWUlJsRmRsLXZBa25GZUhlQ3AwLWd4amVwRFdVcF9DenR2SE9yRmEwN1FjMk1oSHVRRjdqM3lWZjg0Z3ZEQVlWbkNNTXRrMS1GSkFFYUlUWUZWWlZ0VkhaeHRJOE13Z1g4T1pJdXNMSzktaFZkNTFJcG1rbmpRU0ZyZ1c2dWFYaUNhVjlCMm9CaWtiTXYxbTFPLWVQRGgxQmI1dS1HMlU?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWhUMHBhZWxSck5GSnVOVkJoVFJDakFSaTJBaWdCTWdZQlVJb0xzZ1U=-w400-h224-p-df-rw",
    "source": "Bloomberg",
    "datetime": "2024-05-29T07:00:00.000Z",
    "time": "May 29",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk, Eli Lilly rake in cash from weight-loss drugs",
    "link": "https://news.google.com/read/CBMimwFBVV95cUxNWGRlSWVBaDhRZmxlZ0VOMTVHcGJYRUt3ZGFENW9WU2RjUWZEbnU2aS1zN3ZFMWJXd3h1elpVNnVQd2J3V2ZHVWlGTDI2ZHE5OXpxS0ZIS3pGY2tHR09QRGk4OVRfSFNjczU2YXdVSUNpeFlZVWJ0S3BrblExcE9URVR4SEJBd2tRamtZd2ZVQ29ObWFFZlo4ZFJKTQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNVNNakJCVFVwb1dXeFVVa3hOVFJDM0FSaVRBaWdCTWdZUlJKQ0txUVk=-w400-h224-p-df-rw",
    "source": "The Washington Post",
    "datetime": "2023-11-02T07:00:00.000Z",
    "time": "Nov 2, 2023",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply",
    "link": "https://news.google.com/read/CBMinAFBVV95cUxNeFBwVG0tc1kxSFIzS1NCb0dmY3ViRGZ1dXpQZWFaemFXTlA1bTV3NTBsczlnay1NMGZXOEdNM044U3J3WHl3cDJJSGJDdGhweUNUVW1ZekxHRkNnemowZzh2Mk1RR1p4aVBaZlZFTVg5Y0JYSnpsMlF1YUdQTXdGblM0MkVwallNN1IwLUtmZUVPMEUtWmpwRUFyVm3SAaIBQVVfeXFMTm1iMUlvS0Fqc09MRzVHbE1TYkloY1lQSGhmR1h0dzJhaHFPWTBEem5ScDFXdzFlN0NOTU9rR3hIcy11anNtUUlWc21Udjl1amIyZmxjSzZGV1JheFUtOGxHWEFTbzdwYWxUQUNZUTlUMFh4eUtuRXdrWXIwWjh0WkJJa1RWYXNRaUJrWHczQkpaZWhvNE95NlZtS2FxUUowVmV3?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNXdSRlJUZEVOeWVsVTRjMDkxVFJDb0FSaXNBaWdCTWdNTkVBNA=-w400-h224-p-df-rw",
    "source": "CNBC",
    "datetime": "2024-02-05T08:00:00.000Z",
    "time": "Feb 5",
    "articleType": "regular"
  },
  {
    "title": "Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance",
    "link": "https://news.google.com/read/CBMiqwFBVV95cUxPNUNLeTdkUllYZDc2d1BreWdyYl9UZDB4V2trMUxRb0llajdVNy1qckd3SlVXWXdFSUZkNnA0Y2tPSkNuVFphajA4TFl5Y1YzaU51N2VzQ1YwZjBSRWhrR1EwN1B5QXBMWlBJMl9Xei1kTzVfVFB4YlppdXZWaU9MeDlhRzJPSmF1NG9MVW5BbkJqOHh0WUI2ZEppbURnc1NOVHJHMjBlTVBuTjDSAbABQVVfeXFMUGhILUxQZ0FUYWxSWU9paGc0SzRlUUJVS05zY1NLUi13M3hQOUZXQi16Yk5VMFZZZjNVWTJPLUR3ODJ3ZU5Sa2JEZU5RajdfYlpfM1BNQ2IwVjNqRjcxT3VYTWNWS3liNjg3TVVWakVrcTlkd0F6RzY4c0ExMEoxU2s3N2JkTGdSWVh0SnF6enRXYUJ4dTZYcWJWRkRFM3pad2N6YURSZW42MlFLcWFucEc?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNUNaMHR3YWs1d2JXWkRiMGwzVFJDb0FSaXNBaWdCTWdZWlU0NkxKUVk=-w400-h224-p-df-rw",
    "source": "CNBC",
    "datetime": "2024-05-07T07:00:00.000Z",
    "time": "May 7",
    "articleType": "regular"
  },
  {
    "title": "Novo Nordisk Threatens Legoâ€™s Position as Denmarkâ€™s No. 1 Brand",
    "link": "https://news.google.com/read/CBMiswFBVV95cUxOOVVCb21LejkxbmZuSmtRQjc2N2F2WXRVU29VMkxVdjQwU3FyU3BCYTNSZDR1dVFHR19uakRFTDNvd1daV29aWEZjRlFuZlZWWDRpeEhDOXdBN2lERHg2c2kzR1EzWjRUUktUMl9fM0pUQ3ZvYk5xVmVUOUhCQ0R4bGJKc3JiczNLQWVWNkM5Qkw3N2F4eHpQUWp5cXJNWEQ2YnpmQmgxcXlvUzJLLTB4T3NHVQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iL0NnNXhabHB0WjNkdFkzSldaSEYyVFJDM0FSaVRBaWdCTWdtVlVveExzZVdDcUFJ=-w400-h224-p-df-rw",
    "source": "Bloomberg",
    "datetime": "2024-06-12T07:00:00.000Z",
    "time": "Jun 12",
    "articleType": "regular"
  }
]